“Personalize My Treatment (PMT) Registry”
The 'Personalize My treatment' (PMT) platform is a novel form of biobanking in which cancer patients willingly consent to provide residual, clinical samples (surplus after diagnostic testing) of their tumors for cancer research, to give access to their medical record for data collection and then followed prospectively throughout the trajectory of their illness. They further willingly consent to be recontacted for being informed of other research projects, including clinical trials.
Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.
A Large-scale Longitudinal Oncology Registry